Weissella cibaria Attenuated LPS-Induced Dysfunction of Intestinal Epithelial Barrier in a Caco-2 Cell Monolayer Model

Liping Huang,Kang Cui,Wenhao Mao,Yurong Du,Ning Yao,Zhen Li,Huan Zhao,Wang Ma

DOI: https://doi.org/10.3389/fmicb.2020.02039

IF: 5.2

2020-09-03

Frontiers in Microbiology

Abstract:The dysfunction of the intestinal epithelial barrier contributes to local or systemic infection and inflammation. Some lactic acid bacteria (LAB) strains had been shown to improve the conditions of barrier function and, for this reason, are recognized as probiotics. Weissella cibaria, a species belonging to the LAB group, is known to promote several health benefits. However, the role of W. cibaria in regulating the integrity of the intestinal epithelial barrier has not yet been investigated. In this study, W. cibaria MW01 was isolated from Chinese sauerkraut and was selected based on its functional features, such as gastric juice and bile salt tolerance, besides antagonistic activity against pathogenic bacteria. In a cellular model of the intestinal barrier, it was observed that W. cibaria was able to adhere more efficiently than Lactobacillus rhamnosus GG in Caco-2 cells. Moreover, the LPS-induced inflammation in Caco-2 cells was attenuated by the treatment with W. cibaria MW01, which reduced the synthesis of TNF-α, IL-6, and IL-8. In addition, it was noted that the treatment with W. cibaria MW01 recovered the integrity of the Caco-2 cell monolayer exposed to LPS. Furthermore, W. cibaria MW01 significantly alleviated LPS-induced downregulation of tight junction proteins (TJP) (claudin, occludin, and tight junction protein-1). Mechanistically, W. cibaria MW01 inhibited the translocation of NF-κB to the nucleus and deactivated the MLCK-pMLC pathway during LPS exposure. Thus, W. cibaria MW01, as a potential probiotic, can protect intestinal epithelial barrier function by regulating inflammation and expression of TJP via the NF-κB-mediated MLCK-pMLC pathway.

microbiology

What problem does this paper attempt to address?

The paper aims to explore the role of a specific strain of the genus Lactobacillus—Weissella cibaria MW01—in regulating intestinal epithelial barrier function. Specifically, the study seeks to address whether Weissella cibaria can alleviate intestinal epithelial barrier dysfunction induced by lipopolysaccharide (LPS). Using a Caco-2 cell monolayer model, the researchers evaluated the effects of Weissella cibaria MW01 on LPS-induced inflammatory response, tight junction protein expression, and epithelial barrier integrity. The background of the study indicates that dysfunction of the intestinal epithelial barrier is associated with local or systemic infections and inflammation, and certain strains of Lactobacillus have been shown to improve barrier function, thus being identified as probiotics. Weissella cibaria MW01 was isolated from Chinese pickles and was selected for its tolerance to gastric juice and bile salts, as well as its antagonistic activity against pathogenic bacteria. The study results showed that Weissella cibaria MW01 could effectively adhere to Caco-2 cells and mitigate LPS-induced inflammatory responses, reducing the synthesis of TNF-α, IL-6, and IL-8. Additionally, Weissella cibaria MW01 was able to restore the integrity of the Caco-2 cell monolayer exposed to LPS, significantly alleviating the downregulation of tight junction proteins (such as claudin, occludin, and tight junction protein-1) induced by LPS. Mechanistically, Weissella cibaria MW01 inhibited the translocation of NF-κB to the nucleus and inactivated the MLCK-pMLC pathway during LPS exposure. Therefore, Weissella cibaria MW01, as a potential probiotic, can protect intestinal epithelial barrier function by regulating inflammatory responses and the expression of tight junction proteins, with its mechanism possibly involving the NF-κB-mediated MLCK-pMLC pathway.

Weissella cibaria Attenuated LPS-Induced Dysfunction of Intestinal Epithelial Barrier in a Caco-2 Cell Monolayer Model

Lactobacillus rhamnosus CY12 Enhances Intestinal Barrier Function by Regulating Tight Junction Protein Expression, Oxidative Stress, and Inflammation Response in Lipopolysaccharide-Induced Caco-2 Cells

Clostridium Tyrobutyricum Protect Intestinal Barrier Function from LPS-Induced Apoptosis Via P38/JNK Signaling Pathway in IPEC-J2 Cells

A Potential Probiotic for Diarrhea: Clostridium tyrobutyricum Protects Against LPS-Induced Epithelial Dysfunction via IL-22 Produced By Th17 Cells in the Ileum

Heat-Killed Lacticaseibacillus paracasei Repairs Lipopolysaccharide-Induced Intestinal Epithelial Barrier Damage via MLCK/MLC Pathway Activation

Lactobacillus reuteri ZJ617 maintains intestinal integrity via regulating tight junction, autophagy and apoptosis in mice challenged with lipopolysaccharide.

Lactiplantibacillus plantarum ST-III and Lacticaseibacillus rhamnosus KF7 Enhance the Intestinal Epithelial Barrier in a Dual-Environment In Vitro Co-Culture Model

Lacticaseibacillus paracasei CCFM1222 Ameliorated the Intestinal Barrier and Regulated Gut Microbiota in Mice with Dextran Sulfate Sodium-Induced Colitis

Protective Effects of a Novel Probiotic Bifidobacterium pseudolongum on the Intestinal Barrier of Colitis Mice via Modulating the Pparγ/STAT3 Pathway and Intestinal Microbiota

Lactobacillus gasseri ATCC33323 affects the intestinal mucosal barrier to ameliorate DSS-induced colitis through the NR1I3-mediated regulation of E-cadherin

Multi-Species Probiotic Strain Mixture Enhances Intestinal Barrier Function by Regulating Inflammation and Tight Junctions in Lipopolysaccharides Stimulated Caco-2 Cells

Synergistic Protective Effect of Konjac Mannan Oligosaccharides and Bacillus subtilis on Intestinal Epithelial Barrier Dysfunction in Caco-2 Cell Model and Mice Model of Lipopolysaccharide Stimulation

Secretions of Bifidobacterium infantis and Lactobacillus acidophilus Protect Intestinal Epithelial Barrier Function.

Bifidobacterium dentium N8 with potential probiotic characteristics prevents LPS-induced intestinal barrier injury by alleviating the inflammatory response and regulating the tight junction in Caco-2 cell monolayers

Clostridium butyricum protects intestinal barrier function via upregulation of tight junction proteins and activation of the Akt/mTOR signaling pathway in a mouse model of dextran sodium sulfate-induced colitis

Lactobacillus reuteri 1 Enhances Intestinal Epithelial Barrier Function and Alleviates the Inflammatory Response Induced by Enterotoxigenic Escherichia coli K88 via Suppressing the MLCK Signaling Pathway in IPEC-J2 Cells

Lactobacilli sp. mixture alleviates LPS-induced inflammation in Caco-2 intestinal cell line

A Novel Postbiotic From Lactobacillus rhamnosus GG With a Beneficial Effect on Intestinal Barrier Function

Probiotic Lactobacillus plantarum Promotes Intestinal Barrier Function by Strengthening the Epithelium and Modulating Gut Microbiota

Selection of Fermentation Supernatant from Probiotic Strains Exhibiting Intestinal Epithelial Barrier Protective Ability and Evaluation of Their Effects on Colitis Mouse and Weaned Piglet Models

Pasteurized Akkermansia muciniphila Ameliorate the LPS-Induced Intestinal Barrier Dysfunction via Modulating AMPK and NF-κB through TLR2 in Caco-2 Cells